CATHETER II STUDY - RANDOMISED CONTROLLED TRIAL COMPARING THE CLINICAL AND COST-EFFECTIVENESS OF VARIOUS WASHOUT POLICIES VERSUS NO WASHOUT POLICY IN PREVENTING CATHETER ASSOCIATED COMPLICATIONS IN ADULTS LIVING WITH LONG-TERM CATHETERS.

Project: Grant

Project Details

Project Name

The CATHETER II study: Randomised Controlled Trial CompAring THE Clinical And CosT-Effectiveness Of VaRious Washout Policies Versus No Washout Policy In Preventing Catheter Associated Complications In Adults Living With Long-Term Catheters

Description / Abstract

Urinary catheters are soft tubes inserted into the bladder to drain urine. They are often used to help people with urinary incontinence and/or retention. The same type of catheter is used for men and women. In the UK, it has been estimated that in average 1:500 live with long-term catheters (LTC); rising significantly among patients living in care homes. LTC can be associated with number complications such as catheter blockage and urinary tract infections. These complications impact considerably on patients' quality of life. We know this from interviews with patients that use LTC (www.healthtalk.org). They also have a substantial impact on NHS resources due to frequent emergency visits to and from nurses and GPs. Currently the best practice for LTC care is individualised to each patient's needs and includes patient education about how to look after their LTC. Examples are hands and catheter hygiene; drinking plenty of water; and instructions on how to secure their catheter. Patients normally change their catheter bags every week while the catheter itself is changed by a nurse every 10-12 weeks in average (can differ according to type of catheter and patients circumstances). Current research tells us that catheter blockages may affect up-to half of all people with LTCs causing them significant pain, anxiety, incontinence and reliance on health resources including out of hours nursing visits and/or hospital admissions. There are two broad strategies to deal with the prevention and management of catheter blockage: more frequent change of the catheter and/or the use of liquid washout solutions to flush the catheters. Although the current clinical guidelines do not recommend prophylactic LTC washouts, they are currently used in clinical practice to prevent LTC blockage. We really don't know enough about the benefits or harms of LTC washouts and whether we should recommend their widespread use or not. Nor do we know what the extra costs or savings for the NHS that might arise if prophylactic washouts were used routinely. Patients, doctors and nurses all agree that more and better research is urgently needed to try and answer these questions. We have designed a study specifically for this purpose, in our study patients with LTC have an equal chance of receiving either standard catheter care with or without prophylactic weekly catheter washouts. Patients that get a washout will receive either citric acid or saline fluid, so we can compare their effects on important outcomes. We will keep in touch with patients for 2 years and evaluate a range of outcome measures including the number of catheter blockages; catheter-associated urinary tract infections and other complications. We will also measure how satisfied patients are with the interventions they received, their quality of life, and any costs they experience, in addition to the costs to the NHS. We also think it is important to interview patients, nurses and doctors to explore their views, attitudes, experiences and expectations of washouts strategy. Our team of researchers and health professionals has a great deal of experience in designing and delivering studies of this nature. The team includes patients, nurses, urologists, GPs, and research leaders from the University of Aberdeen. We established a partnership with the Royal College of Nursing, British Association of Urology Nurses and Ageing UK to help us contact patients and nurses in the community and care homes. We are also working with Bladder Health UK (patient charity) to ensure our research is relevant to patients.
StatusFinished
Effective start/end date1/10/1829/02/24